Blister.jpg (Blister)
Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 50090-2594
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 50090-2594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1.jpg (Figure1)
The text mentions different types of statistical measures such as Hazard Ratio, Rate Ratio, Odds Ratio, and studies like FDA-funded study, Danish re-analysis, MEGA study, and GPRD study. The studies include prospective cohort studies and case-control studies. Specific details on different research projects and their findings are provided.*
Figure2.jpg (Figure2)
Logo.jpg (Logo)
A description is not available.*
Structure-drospirenone.jpg (Structure Drospirenone)
Structure-ethinyl.jpg (Structure Ethinyl)
Chart (Chart)
This text provides information on different contraceptive methods based on the number of pregnancies per 100 women in a year, ranging from options for fewer pregnancies to more pregnancies. It lists various forms of contraception such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring, condoms, diaphragm, and methods like no sex during fertile days, spermicide, withdrawal, and no birth control.*
Label Image (Lbl500902594)
Serious-blood-clot (Serious Blood Clot)
The text provides information on blood clot incidents in women during different stages such as Non-Pregnant, Postpartum (up to 12 weeks), and Pregnancy. It includes the number of blood clot cases out of 10,000 Women Years for each stage. Additionally, it discusses the model assumption that pregnancy duration is nine months and the associated rate of blood clot incidents during pregnancy.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
